Genomic alterations in uterine leiomyosarcomas: Potential markers for clinical diagnosis and prognosis.

被引：0
|
作者：
Hu, J
Khanna, V
Jones, M
Surti, U
机构：
[1] UPMC Hlth Syst, Dept Genet, Magee Womens Hosp, Pittsburgh, PA USA
[2] UPMC Hlth Syst, Dept Pathol, Magee Womens Hosp, Pittsburgh, PA USA
[3] Magee Womens Res Inst, Pittsburgh, PA USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2000年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
311
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [1] Genomic alterations in uterine leiomyosarcomas: Potential markers for clinical diagnosis and prognosis
    Hu, J
    Khanna, V
    Jones, M
    Surti, U
    GENES CHROMOSOMES & CANCER, 2001, 31 (02): : 117 - 124
  • [2] Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas
    Guo, Jialu
    Zheng, Jianfeng
    Tong, Jinyi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (07): : 1227 - 1240
  • [3] Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization
    Packenham, JP
    duManoir, S
    Schrock, E
    Risinger, JI
    Dixon, D
    Denz, DN
    Evans, JAC
    Berchuck, A
    Barrett, JC
    Devereux, TR
    Ried, T
    MOLECULAR CARCINOGENESIS, 1997, 19 (04) : 273 - 279
  • [4] Comprehensive Genomic Profiling of Uterine Leiomyosarcomas Identifies Frequent Clinically Relevant Genomic Alterations and Opportunities for Personalized Therapies
    Gunderson, Camille C.
    Santin, A.
    delPrior, G.
    Elvin, J. A.
    Ramkissoon, S.
    Ali, S. M.
    McMahon, C.
    Fabrizio, D.
    Chalmers, Z.
    Frampton, G. M.
    Chmielecki, J.
    Vergilio, J.
    Suhn, J.
    Gay, L.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    Moore, K. N.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 208 - 209
  • [5] Genomic alterations as potential clonality markers in esophageal adenocarcinoma
    Dinjens, W.
    Van Nistelrooij, A.
    Koppert, L.
    Biermann, K.
    Wijnhoven, B.
    VIRCHOWS ARCHIV, 2014, 465 : S3 - S4
  • [6] RS3PE syndrome: a clinical diagnosis challenge for a good prognosis.
    Roblot, P
    Zaim, A
    Azais, I
    Ramassamy, A
    Paccalin, M
    Becq-Giraudon, B
    REVUE DE MEDECINE INTERNE, 1998, 19 (08): : 542 - 547
  • [7] Tropomyosin Is Potential Markers for the Diagnosis and Prognosis of Bladder Cancer
    Yan, Yunkun
    Li, Jianchang
    Ye, Mushi
    Li, Zhuo
    Li, Sining
    DISEASE MARKERS, 2022, 2022
  • [8] Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets
    Yoshida, Noriaki
    Miyoshi, Hiroaki
    Ohshima, Koichi
    CANCERS, 2021, 13 (08)
  • [9] Genomic profiling of uterine leiomyosarcomas reveal frequent alterations in Akt/mammalian target of rapamycin (mTOR) pathway genes and other actionable genomic abnormalities linked to targeted therapies
    Elvin, J. A.
    Chalmers, Z. R.
    Chiemlicki, J.
    Wang, K. A. I.
    Palma, N.
    Ali, S. M.
    Huho, A.
    Sheehan, C. E.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 104 - 104
  • [10] Molecular Analysis of Uterine Myxoid Sarcomas Shows Absence of BCOR Alterations in Myxoid Leiomyosarcomas and Improves the Diagnosis of Morphologically Ambiguous Lesions
    Schmelkin, Cindy
    Marino-Enriquez, Adrian
    Nucci, Marisa
    Parra-Herran, Carlos
    LABORATORY INVESTIGATION, 2019, 99
12345